COMPARISON OF EFFECT OF LOW DOSE DEXMEDETOMIDINE INFUSION (0.2 VS 0.4 MCG/KG/HR) ON HEMODYNAMIC STRESS RESPONSE IN PATIENTS UNDERGOING LAPROSCOPIC CHOLECYSTECTOMY UNDER GENERAL ANESTHESIA AT TERTIARY CARE HOSPITAL KARACHI
Main Article Content
Keywords
Anesthesia, Dexmedetomidine, Hemodynamic Response, Laparoscopic Cholecystectomy
Abstract
Background: Dexmedetomidine, an α2-adrenergic receptor agonist, has gained prominence for its hemodynamic stabilizing properties in anesthesia. Its dose-dependent effects on reducing stress responses during laparoscopic surgeries remain underexplored.
Objective: To compare the effects of low-dose dexmedetomidine infusion at 0.2 mcg/kg/h versus 0.4 mcg/kg/h on the hemodynamic stress response in patients undergoing laparoscopic cholecystectomy under general anesthesia.
Study Design and Setting: This randomized controlled trial was conducted from November 2020 to March 2021 at the Department of Anesthesiology, Civil Hospital Karachi.
Methodology: A total of 182 patients (91 per group) of ASA status ≤2, aged 20–60 years, were randomly assigned to receive dexmedetomidine infusions at 0.2 mcg/kg/h (Group A) or 0.4 mcg/kg/h (Group B). Hemodynamic parameters, including pulse rate (PR) and mean arterial pressure (MAP), were recorded at predefined intervals.
Results: Group B demonstrated significantly lower pulse rates and mean arterial pressures compared to Group A at all measured time points. For example, at 1 minute post-intubation, the pulse rate was 96.57 ± 3.52 in Group A versus 86.98 ± 1.06 in Group B (p = 0.001). Similarly, MAP was 101.1 ± 9.54 mmHg in Group A versus 94.69 ± 1.58 mmHg in Group B (p = 0.001). These differences persisted post-stratification for variables such as age, gender, BMI, and surgical duration.
Conclusion: A dexmedetomidine infusion at 0.4 mcg/kg/h is more effective in attenuating the hemodynamic stress response during laparoscopic cholecystectomy compared to 0.2 mcg/kg/h, with statistically significant reductions in pulse rate and mean arterial pressure.
References
2. Chaparro CM, Neufeld LM, Tena Alarez G, Equia-Liz-Cedillo R, Dewey KG. Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomized controlled trial. Lancet 2006;367:1997-04.
3. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–05.
4. Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol. 2008;21:457–61.
5. Isik B, Arslan M, Özsoylar O, Akçabay M. The effects of α2-adrenergic receptor agonist dexmedetomidine on hemodynamic response in direct laryngoscopy. Open Otorhinolaryngol J. 2007;1:5–11.
6. Gurbet A, Basagan-Mogol E, Turker G, Ugun F, Kaya FN, Ozcan B. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements. Can J Anaesth. 2006;53:646–52.
7. Feld JM, Hoffman WE, Stechert MM, Hoffman IW, Ananda RC. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18:24–8.
8. Ramsay MA, Saha D, Hebeler RF. Tracheal resection in the morbidly obese patient: The role of dexmedetomidine. J Clin Anesth. 2006;18:452–4.
9. Tufanogullari B, White PF, Peixoto MP, Kianpour D, Lacour T, Griffin J, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: The effect on recovery outcome variables. Anesth Analg. 2008;106:1741–8.
10. Lin TF, Yeh YC, Lin FS, Wang YP, Lin CJ, Sun WZ, et al. Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia. Br J Anaesth. 2009;102:117–22.
11. Haselman MA. Dexmedetomidine: A useful adjunct to consider in some high-risk situations. AANA J. 2008;76:335–9.
12. Bhattacharjee DP, Nayek SK, Dawn S, Bandopadhyay G, Gupta K. Effects of dexmeditomidine on haemodynamics in patients undergoing laparoscopic cholecystectomy – a comparative study. J Anaesth Clin Pharmacol. 2010;2:45–8.
13. Keniya VM, Ladi S, Naphade R. Dexmedetomidine attenuates sympathoadrenal response to tracheal intubation and reduces perioperative anaesthetic requirement. Indian J Anaesth. 2011;55:352–7.
14. Shehabi Y, Botha JA, Ernest D, Freebairn RC, Reade M, Roberts BL, et al. Clinical application, the use of dexmedetomidine in intensive care sedation. Crit Care Shock. 2010;13:40–50.
15. Abdelmageed WM, Elquesny KM, Shabana RI, Abushama HM, Nassar AM. Analgesic properties of a dexmedetomidine infusion after uvulopalatopharyngoplasty in patients with obstructive sleep apnea. Saudi J Anaesth. 2011;5:150–6.
16. Manne GR, Upadhyay MR, Swadia V. Effects of low dose dexmedetomidine infusion on haemodynamic stress response, sedation and post-operative analgesia requirement in patients undergoing laparoscopic cholecystectomy. Indian J Anaesth. 2014 Nov-Dec;58(6):726-31.
17. Deepali, Dhanajay Kumar, K.K. Arora. To evaluate the effectiveness of intravenous dexmedetomidine infusion during laproscopic cholecystectomy. a prospective randomised placebo control study. Intern J Contemporary Med Res 2019;6(5):E25-E28.
18. Bhattacharjee DP, Saha S, Paul S, Roychowdhary S, Mondal S, Paul S. A comparative study of esmolol and dexmedetomidine on hemodynamic responses to carbon dioxide pneumoperitoneum during laparoscopic surgery. Anesth Essays Res. 2016;10:580-4
19. Godhki PS, Thombre SK, Sardesi SP, Hamagle KD. Dexmedetomidine as an anaesthetic adjuvant in laparascopic surgery: An observational study using entropy monitoring. J Anaesthesiol Clin Pharmacol. 2012;28:334-8.
20. Jan S, Ahmad T, Rashid S. Dexmedetomidine Infusion an Effective Intra-Operative Medication for Patients Undergoing Laparoscopic Cholecystectomy. Int J Anesthetic Anesthesiol 2018;5:083.